• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛇床子素治疗动物高脂血症和酒精性脂肪肝的实验研究

Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals.

作者信息

Song Fang, Xie Mei-Lin, Zhu Lu-Jia, Zhang Ke-Ping, Xue Jie, Gu Zhen-Lun

机构信息

Department of Pharmacology, Medical School of Soochow University, Suzhou 215123, Jiangsu Province, China.

出版信息

World J Gastroenterol. 2006 Jul 21;12(27):4359-63. doi: 10.3748/wjg.v12.i27.4359.

DOI:10.3748/wjg.v12.i27.4359
PMID:16865778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4087747/
Abstract

AIM

To evaluate the effects of osthole on fatty liver, and investigate the possible mechanism.

METHODS

A quail model with hyperlipidemic fatty liver and rat model with alcoholic fatty liver were set up by feeding high fat diet and alcohol, respectively. These experimental animals were then treated with osthole 5-20 mg/kg for 6 wk, respectively. Whereafter, the lipid in serum and hepatic tissue, and coefficient of hepatic weight were measured.

RESULTS

After treatment with osthole the levels of serum total cholesterol (TC), triglyceride (TG), lower density lipoprotein-cholesterol (LDL-C), coefficient of hepatic weight, and the hepatic tissue contents of TC and TG were significantly decreased. The activity of superoxide dismutase (SOD) in liver was improved. In alcohol-induced fatty liver rats, the level of malondialdehyde (MDA) in liver was decreased. In high fat-induced fatty liver quails, glutathione peroxidase (GSH-PX) in liver was significantly improved. The histological evaluation of liver specimens demonstrated that the osthole dramatically decreased lipid accumulation.

CONCLUSION

These results suggested that osthole had therapeutic effects on both alcohol and high fat-induced fatty liver. The mechanism might be associated with its antioxidation.

摘要

目的

评估蛇床子素对脂肪肝的影响,并探讨其可能的作用机制。

方法

分别通过高脂饮食和酒精喂养建立高脂血症脂肪肝鹌鹑模型和酒精性脂肪肝大鼠模型。然后分别用5 - 20mg/kg蛇床子素对这些实验动物进行6周治疗。之后,测定血清和肝组织中的脂质以及肝重系数。

结果

蛇床子素治疗后,血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL - C)水平、肝重系数以及肝组织中TC和TG含量均显著降低。肝脏中超氧化物歧化酶(SOD)活性得到改善。在酒精性脂肪肝大鼠中,肝脏中丙二醛(MDA)水平降低。在高脂性脂肪肝鹌鹑中,肝脏中谷胱甘肽过氧化物酶(GSH - PX)显著改善。肝脏标本的组织学评估表明,蛇床子素显著降低了脂质蓄积。

结论

这些结果表明,蛇床子素对酒精性和高脂性脂肪肝均有治疗作用。其机制可能与其抗氧化作用有关。

相似文献

1
Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals.蛇床子素治疗动物高脂血症和酒精性脂肪肝的实验研究
World J Gastroenterol. 2006 Jul 21;12(27):4359-63. doi: 10.3748/wjg.v12.i27.4359.
2
Inhibitory effect of osthole on alcohol-induced fatty liver in mice.蛇床子素对小鼠酒精性脂肪肝的抑制作用。
Dig Liver Dis. 2009 Feb;41(2):127-33. doi: 10.1016/j.dld.2008.01.011. Epub 2008 Mar 12.
3
Osthole improves alcohol-induced fatty liver in mice by reduction of hepatic oxidative stress.蛇床子素通过减少肝氧化应激改善酒精性脂肪肝。
Phytother Res. 2011 May;25(5):638-43. doi: 10.1002/ptr.3315. Epub 2010 Oct 27.
4
Therapeutic effect of osthole on hyperlipidemic fatty liver in rats.蛇床子素对大鼠高脂血症性脂肪肝的治疗作用
Acta Pharmacol Sin. 2007 Mar;28(3):398-403. doi: 10.1111/j.1745-7254.2007.00533.x.
5
Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gamma-mediated lipogenic gene expression.蛇床子素改善大鼠脂肪乳诱导的脂肪肝:对肝脏PPAR-α/γ介导的脂肪生成基因表达的调节
Planta Med. 2007 Jul;73(8):718-24. doi: 10.1055/s-2007-981552. Epub 2007 Jul 5.
6
Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.蛇床子素通过增加高脂肪高蔗糖诱导的脂肪肝大鼠脂联素的释放来改善胰岛素抵抗。
Planta Med. 2011 Feb;77(3):231-5. doi: 10.1055/s-0030-1250268. Epub 2010 Aug 17.
7
[Effect of Ganoderma lucidum polysaccharides on oxidative stress of hyperlipidemic fatty liver in rats].灵芝多糖对高脂血症性脂肪肝大鼠氧化应激的影响
Zhongguo Zhong Yao Za Zhi. 2012 Oct;37(20):3102-6.
8
Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.绞股蓝总皂苷对高脂高胆固醇饮食和酒精诱导的大鼠脂肪肝的保护作用。
Arch Pharm Res. 2012 Jul;35(7):1241-50. doi: 10.1007/s12272-012-0715-5. Epub 2012 Aug 3.
9
Protective effects of diosgenin in the hyperlipidemic rat model and in human vascular endothelial cells against hydrogen peroxide-induced apoptosis.薯蓣皂苷元在高脂血症大鼠模型和人血管内皮细胞中对过氧化氢诱导的细胞凋亡的保护作用。
Chem Biol Interact. 2010 Mar 30;184(3):366-75. doi: 10.1016/j.cbi.2010.02.005. Epub 2010 Feb 10.
10
Effect of Cydonia oblonga Mill. leaf extract on serum lipids and liver function in a rat model of hyperlipidaemia.黑枣叶提取物对高脂血症大鼠血脂和肝功能的影响。
J Ethnopharmacol. 2014 Feb 3;151(2):970-4. doi: 10.1016/j.jep.2013.12.010. Epub 2013 Dec 14.

引用本文的文献

1
Exploring the Toxicity and Therapeutic Potential of and in Zebrafish Larvae: Insights into Anxiety Treatment Mechanisms.探索[具体物质1]和[具体物质2]对斑马鱼幼体的毒性及治疗潜力:深入了解焦虑症治疗机制
Int J Mol Sci. 2025 Mar 22;26(7):2884. doi: 10.3390/ijms26072884.
2
The Effect of Osthole on Transient Receptor Potential Channels: A Possible Alternative Therapy for Atopic Dermatitis.蛇床子素对瞬时受体电位通道的影响:特应性皮炎的一种可能替代疗法。
J Inflamm Res. 2024 Feb 9;17:881-898. doi: 10.2147/JIR.S425978. eCollection 2024.
3
Osthole Regulates Secretion of Pro-Inflammatory Cytokines and Expression of and in Normal Human Keratinocytes and Fibroblasts.蛇床子素调节正常人角质形成细胞和成纤维细胞中促炎细胞因子的分泌以及[具体基因名称缺失]和[具体基因名称缺失]的表达。
J Inflamm Res. 2022 Mar 1;15:1501-1519. doi: 10.2147/JIR.S349216. eCollection 2022.
4
Effects of Osthole on Inflammatory Gene Expression and Cytokine Secretion in Histamine-Induced Inflammation in the Caco-2 Cell Line.蛇床子素对组胺诱导的 Caco-2 细胞系炎症中炎症基因表达和细胞因子分泌的影响。
Int J Mol Sci. 2021 Dec 20;22(24):13634. doi: 10.3390/ijms222413634.
5
Osthole: A Coumarin Derivative Assuage Thiram-Induced Tibial Dyschondroplasia by Regulating and Expressions in Chickens.蛇床子素:一种香豆素衍生物,通过调节鸡体内的[具体物质]和[具体物质]表达减轻福美双诱导的胫骨软骨发育不良。
Antioxidants (Basel). 2019 Aug 22;8(9):330. doi: 10.3390/antiox8090330.
6
Application of Metabolomics in the Study of Natural Products.代谢组学在天然产物研究中的应用。
Nat Prod Bioprospect. 2018 Aug;8(4):321-334. doi: 10.1007/s13659-018-0175-9. Epub 2018 Jun 29.
7
Metabolic map of osthole and its effect on lipids.蛇床子素的代谢图谱及其对脂质的影响。
Xenobiotica. 2018 Mar;48(3):285-299. doi: 10.1080/00498254.2017.1306660. Epub 2017 Apr 3.
8
PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats.PPARα/γ 拮抗剂逆转蛇床子素对脂肪性肝炎大鼠肝脂代谢和炎症反应的改善作用。
Inflammopharmacology. 2018 Apr;26(2):425-433. doi: 10.1007/s10787-017-0327-2. Epub 2017 Feb 25.
9
Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding.鼠李糖乳杆菌CCFM1107治疗可改善慢性酒精喂养小鼠模型中酒精诱导的肝损伤。
J Microbiol. 2015 Dec;53(12):856-63. doi: 10.1007/s12275-015-5239-5. Epub 2015 Dec 2.
10
Osthole: A Review on Its Bioactivities, Pharmacological Properties, and Potential as Alternative Medicine.蛇床子素:关于其生物活性、药理特性及作为替代医学潜力的综述
Evid Based Complement Alternat Med. 2015;2015:919616. doi: 10.1155/2015/919616. Epub 2015 Jul 13.

本文引用的文献

1
Nonalcoholic fatty liver disease in developing countries.发展中国家的非酒精性脂肪性肝病
World J Gastroenterol. 2005 Jun 28;11(24):3808-9. doi: 10.3748/wjg.v11.i24.3808.
2
Nonalcoholic fatty liver disease: a review of current understanding and future impact.非酒精性脂肪性肝病:当前认识与未来影响综述
Clin Gastroenterol Hepatol. 2004 Dec;2(12):1048-58. doi: 10.1016/s1542-3565(04)00440-9.
3
Clinical features and risk factors of patients with fatty liver in Guangzhou area.广州地区脂肪肝患者的临床特征及危险因素
World J Gastroenterol. 2004 Mar 15;10(6):899-902. doi: 10.3748/wjg.v10.i6.899.
4
Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.非酒精性脂肪性肝病:一种代谢紊乱的常见表现。
QJM. 2003 Oct;96(10):699-709. doi: 10.1093/qjmed/hcg120.
5
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.非酒精性脂肪性肝炎:美国肝病研究学会单一主题会议总结
Hepatology. 2003 May;37(5):1202-19. doi: 10.1053/jhep.2003.50193.
6
AGA technical review on nonalcoholic fatty liver disease.美国胃肠病学会关于非酒精性脂肪性肝病的技术审查
Gastroenterology. 2002 Nov;123(5):1705-25. doi: 10.1053/gast.2002.36572.
7
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病
J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S186-90. doi: 10.1046/j.1440-1746.17.s1.10.x.
8
Nonalcoholic steatohepatitis.非酒精性脂肪性肝炎
Gastroenterology. 2001 Sep;121(3):710-23. doi: 10.1053/gast.2001.27126.
9
Alcoholic liver disease.酒精性肝病
Postgrad Med J. 2000 May;76(895):280-6. doi: 10.1136/pmj.76.895.280.
10
Prevalence of and risk factors for hepatic steatosis in Northern Italy.意大利北部肝脂肪变性的患病率及危险因素
Ann Intern Med. 2000 Jan 18;132(2):112-7. doi: 10.7326/0003-4819-132-2-200001180-00004.